FDA announces FreeStyle Libre continuous glucose monitor sensor recall

Abbott Diabetes Care has recalled some of its FreeStyle Libre 3 and FreeStyle Libre 3 Plus glucose monitor sensors for people ...
CNET

Check Your CGM: Recalled FreeStyle Libre 3 Sensors Associated With 7 Deaths

This is now a Class I recall, meaning that the use of these continuous glucose monitoring systems could cause serious health ...
KTVU FOX 2

FDA: Certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus Sensors recalled after seven deaths, 860 injuries

The Food and Drug Administration (FDA) has now identified the recall of certain FreeStyle Libre glucose monitor sensors as ...

Diabetes sensors recalled after 7 deaths, hundreds of injuries

Abbott Diabetes Care recalled FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors due to defective readings that show lower ...
American Hospital Association

FDA issues most serious recall for certain glucose monitor sensors

The Food and Drug Administration has identified a Class I recall of certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus Sensors by Abbott Diabetes Care due to incorrect glucose readings that are ...

Abbott glucose monitor sensor recall classified as most serious by FDA

Abbott Laboratories (ABT) stock is down as the FDA classifies the company's recent recall of FreeStyle Libre 3 glucose ...
Fierce Biotech

FDA demands better response from Abbott over Libre inspection violations

Abbott has been hit with a slew of complaints from the FDA in a warning letter related to its continuous glucose monitor (CGM ...
MPR

Incorrect Readings Prompt Recall of Certain Abbott Glucose Sensors

FreeStyle Libre 3 and 3 Plus are continuous glucose monitoring devices indicated for the management of diabetes in patients aged 4 years and older.

Abbott Faces FDA Scrutiny On FreeStyle Libre And Broader Quality Story

Abbott Laboratories (NYSE:ABT) received an FDA warning letter focused on the accuracy and testing of its FreeStyle Libre ...
Columbia Missourian

Popular glucose monitor manufacturer Abbott issues recall on product

Boone Health said Abbott has been assisting with the redistribution of new monitors Freestyle Libre 3 and 3 Plus since recall.
MedTech Dive

Abbott receives FDA warning letter over Freestyle Libre CGMs

Abbott needs to conduct more performance testing to ensure its FreeStyle Libre devices are accurate, FDA inspectors found.
Forbes

2 Million Patients And Beyond: Abbott’s FreeStyle Libre 2 Cleared In The U.S. For Adults And Children With Diabetes

Pharmaceutical and med device giant Abbott (NYSE: ABT) said today that it had received approval from the Food and Drug Administration (FDA) for its next-generation integrated continuous glucose ...